XML 58 R40.htm IDEA: XBRL DOCUMENT
v3.20.4

Schedule I (Tables) | 12 Months Ended
--- | ---
Dec. 31, 2020
Condensed Financial Statements, Captions [Line Items] |
Schedule of Maturities of Long-term Debt [Table Text Block] | Maturities of short-term borrowings and long-term debt for the years ending December 31 are as follows:
(in millions) |  |
2021 |  | $ | 4,800 |
2022 |  | 3,180 |
2023 |  | 2,290 |
2024 |  | 1,665 |
2025 |  | 2,465 |
Thereafter |  | 29,349 |
Parent Company [Member] |
Condensed Financial Statements, Captions [Line Items] |
Condensed Balance Sheet [Table Text Block] | Condensed Financial Information of Registrant (Parent Company Only) UnitedHealth Group Condensed Balance Sheets
(in millions, except per share data) |  | December 31, 2020 |  | December 31, 2019
Assets |  |  |  |
Current assets: |  |  |  |
Cash and cash equivalents |  | $ | 258 |  |  | $ | 46 |
Other current assets |  | 562 |  |  | 787 |
Total current assets |  | 820 |  |  | 833 |
Equity in net assets of subsidiaries |  | 107,714 |  |  | 93,467 |
Long-term notes receivable from subsidiaries |  | 5,021 |  |  | 5,079 |
Other assets |  | 342 |  |  | 794 |
Total assets |  | $ | 113,897 |  |  | $ | 100,173 |
Liabilities and shareholders’ equity |  |  |  |
Current liabilities: |  |  |  |
Accounts payable and accrued liabilities |  | $ | 589 |  |  | $ | 688 |
Current portion of notes payable to subsidiaries |  | 4,882 |  |  | 750 |
Short-term borrowings and current maturities of long-term debt |  | 4,465 |  |  | 3,548 |
Total current liabilities |  | 9,936 |  |  | 4,986 |
Long-term debt, less current maturities |  | 37,815 |  |  | 35,926 |
Long-term notes payable to subsidiaries |  | — |  |  | 1,314 |
Other liabilities |  | 655 |  |  | 331 |
Total liabilities |  | 48,406 |  |  | 42,557 |
Commitments and contingencies (Note 4) |  |  |  |
Shareholders’ equity: |  |  |  |
Preferred stock, $0.001 par value -10 shares authorized; no shares issued or outstanding |  | — |  |  | — |
Common stock, $0.01 par value - 3,000 shares authorized; 946 and 948 issued and outstanding |  | 10 |  |  | 9 |
Additional paid-in capital |  | — |  |  | 7 |
Retained earnings |  | 69,295 |  |  | 61,178 |
Accumulated other comprehensive loss |  | (3,814) |  |  | (3,578) |
Total UnitedHealth Group shareholders’ equity |  | 65,491 |  |  | 57,616 |
Total liabilities and shareholders’ equity |  | $ | 113,897 |  |  | $ | 100,173 |
Condensed Statement of Comprehensive Income [Table Text Block] | Condensed Financial Information of Registrant (Parent Company Only) UnitedHealth Group Condensed Statements of Comprehensive Income
|  | For the Years Ended December 31,
(in millions) |  | 2020 |  | 2019 |  | 2018
Revenues: |  |  |  |  |  |
Investment and other income |  | $ | 194 |  |  | $ | 209 |  |  | $ | 194 |
Total revenues |  | 194 |  |  | 209 |  |  | 194 |
Operating costs: |  |  |  |  |  |
Operating costs |  | 27 |  |  | 38 |  |  | 35 |
Interest expense |  | 1,594 |  |  | 1,580 |  |  | 1,285 |
Total operating costs |  | 1,621 |  |  | 1,618 |  |  | 1,320 |
Loss before income taxes |  | (1,427) |  |  | (1,409) |  |  | (1,126) |
Benefit for income taxes |  | 300 |  |  | 293 |  |  | 251 |
Loss of parent company |  | (1,127) |  |  | (1,116) |  |  | (875) |
Equity in undistributed income of subsidiaries |  | 16,530 |  |  | 14,955 |  |  | 12,861 |
Net earnings |  | 15,403 |  |  | 13,839 |  |  | 11,986 |
Other comprehensive (loss) income |  | (236) |  |  | 582 |  |  | (1,517) |
Comprehensive income |  | $ | 15,167 |  |  | $ | 14,421 |  |  | $ | 10,469 |
Condensed Cash Flow Statement [Table Text Block] | Condensed Financial Information of Registrant (Parent Company Only) UnitedHealth Group Condensed Statements of Cash Flows
|  | For the Years Ended December 31,
(in millions) |  | 2020 |  | 2019 |  | 2018
Operating activities |  |  |  |  |  |
Cash flows from operating activities |  | $ | 8,842 |  |  | $ | 9,275 |  |  | $ | 6,099 |
Investing activities |  |  |  |  |  |
Issuances of notes to subsidiaries |  | (628) |  |  | (2,722) |  |  | (1,420) |
Repayments of notes to subsidiaries |  | 1,089 |  |  | 2,249 |  |  | 1,419 |
Cash paid for acquisitions |  | (7,706) |  |  | (9,645) |  |  | (4,066) |
Return of capital to parent company |  | 943 |  |  | 4,497 |  |  | 4,196 |
Capital contributions to subsidiaries |  | (43) |  |  | (803) |  |  | (1,259) |
Other, net |  | 143 |  |  | 490 |  |  | 4 |
Cash flows used for investing activities |  | (6,202) |  |  | (5,934) |  |  | (1,126) |
Financing activities |  |  |  |  |  |
Common stock repurchases |  | (4,250) |  |  | (5,500) |  |  | (4,500) |
Proceeds from common stock issuances |  | 1,440 |  |  | 1,037 |  |  | 838 |
Cash dividends paid |  | (4,584) |  |  | (3,932) |  |  | (3,320) |
Proceeds from (repayments of) short-term borrowings, net |  | 872 |  |  | 300 |  |  | (201) |
Proceeds from issuance of long-term debt |  | 4,864 |  |  | 5,444 |  |  | 6,935 |
Repayments of long-term debt |  | (3,150) |  |  | (1,750) |  |  | (2,600) |
Proceeds (repayments) of notes from subsidiaries |  | 2,818 |  |  | 1,207 |  |  | (1,127) |
Other, net |  | (438) |  |  | (535) |  |  | (923) |
Cash flows used for financing activities |  | (2,428) |  |  | (3,729) |  |  | (4,898) |
Increase (decrease) in cash and cash equivalents |  | 212 |  |  | (388) |  |  | 75 |
Cash and cash equivalents, beginning of period |  | 46 |  |  | 434 |  |  | 359 |
Cash and cash equivalents, end of period |  | $ | 258 |  |  | $ | 46 |  |  | $ | 434 |
Supplemental cash flow disclosures |  |  |  |  |  |
Cash paid for interest |  | $ | 1,633 |  |  | $ | 1,506 |  |  | $ | 1,294 |
Cash paid for income taxes |  | 4,185 |  |  | 2,590 |  |  | 2,379 |
Schedule of Maturities of Long-term Debt [Table Text Block] | Maturities of short-term borrowings and long-term debt for the years ending December 31 are as follows:
(in millions) |  |
2021 |  | $ | 4,446 |
2022 |  | 3,015 |
2023 |  | 2,125 |
2024 |  | 1,500 |
2025 |  | 2,300 |
Thereafter |  | 29,177 |

X
- Definition Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table. + References No definition available. + Details
Name: | srt_CondensedFinancialStatementsCaptionsLineItems
Namespace Prefix: | srt_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of condensed statement of comprehensive income (loss) including, but not limited to, statements of comprehensive income (loss) of consolidated entities and consolidation eliminations. + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Publisher SEC -Name Regulation S-X (SX) -Number 210 -Section 3 -Paragraph i -Subsection 10 + Details
Name: | srt_CondensedStatementOfComprehensiveIncomeTableTextBlock
Namespace Prefix: | srt_
Data Type: | nonnum:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of condensed balance sheet, including, but not limited to, balance sheets of consolidated entities and consolidation eliminations. + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Publisher SEC -Name Regulation S-X (SX) -Number 210 -Section 3 -Paragraph i -Subsection 10 + Details
Name: | srt_ScheduleOfCondensedBalanceSheetTableTextBlock
Namespace Prefix: | srt_
Data Type: | nonnum:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of condensed cash flow statement, including, but not limited to, cash flow statements of consolidated entities and consolidation eliminations. + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Publisher SEC -Name Regulation S-X (SX) -Number 210 -Section 3 -Paragraph i -Subsection 10 + Details
Name: | srt_ScheduleOfCondensedCashFlowStatementTableTextBlock
Namespace Prefix: | srt_
Data Type: | nonnum:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of maturity and sinking fund requirement for long-term debt. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 470 -SubTopic 10 -Section 50 -Paragraph 1 -URI http://asc.fasb.org/extlink&oid=6802200&loc=d3e1835-112601 + Details
Name: | us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock
Namespace Prefix: | us-gaap_
Data Type: | nonnum:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Details
Name: | srt_ConsolidatedEntitiesAxis=srt_ParentCompanyMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |